Thoughts on OZEM ETF long term potential versus individual GLP-1 pharmaceutical stocks?

I’m looking into exposure to the GLP-1 / weight-loss drug sector and came across the OZEM ETF. I already hold major tech (NVDA) and want some healthcare diversification, but I’m debating between: • Buying OZEM for broad exposure • Or picking individual stocks like LLY / NVO For those who’ve researched this space: – Does OZEM provide meaningful diversification? – Are the fees and holdings worth it? – Is it better for long-term investors than stock-picking here? Not looking for financial advice, just informed opinions and research perspectives.